1. Home
  2. DCI vs BIO Comparison

DCI vs BIO Comparison

Compare DCI & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DCI
  • BIO
  • Stock Information
  • Founded
  • DCI 1915
  • BIO 1952
  • Country
  • DCI United States
  • BIO United States
  • Employees
  • DCI N/A
  • BIO N/A
  • Industry
  • DCI Pollution Control Equipment
  • BIO Biotechnology: Laboratory Analytical Instruments
  • Sector
  • DCI Industrials
  • BIO Industrials
  • Exchange
  • DCI Nasdaq
  • BIO Nasdaq
  • Market Cap
  • DCI 8.4B
  • BIO 8.7B
  • IPO Year
  • DCI 1987
  • BIO N/A
  • Fundamental
  • Price
  • DCI $70.55
  • BIO $320.44
  • Analyst Decision
  • DCI Hold
  • BIO Buy
  • Analyst Count
  • DCI 4
  • BIO 4
  • Target Price
  • DCI $69.67
  • BIO $369.00
  • AVG Volume (30 Days)
  • DCI 471.4K
  • BIO 222.4K
  • Earning Date
  • DCI 08-28-2024
  • BIO 10-24-2024
  • Dividend Yield
  • DCI 1.53%
  • BIO N/A
  • EPS Growth
  • DCI 16.55
  • BIO N/A
  • EPS
  • DCI 3.38
  • BIO N/A
  • Revenue
  • DCI $3,586,300,000.00
  • BIO $2,562,604,000.00
  • Revenue This Year
  • DCI $5.29
  • BIO N/A
  • Revenue Next Year
  • DCI $5.64
  • BIO $4.49
  • P/E Ratio
  • DCI $20.92
  • BIO N/A
  • Revenue Growth
  • DCI 4.53
  • BIO N/A
  • 52 Week Low
  • DCI $57.05
  • BIO $261.59
  • 52 Week High
  • DCI $78.03
  • BIO $384.37
  • Technical
  • Relative Strength Index (RSI)
  • DCI 40.10
  • BIO 50.24
  • Support Level
  • DCI $68.94
  • BIO $311.04
  • Resistance Level
  • DCI $70.70
  • BIO $337.50
  • Average True Range (ATR)
  • DCI 1.24
  • BIO 8.18
  • MACD
  • DCI -0.27
  • BIO -1.35
  • Stochastic Oscillator
  • DCI 17.35
  • BIO 43.70

About DCI Donaldson Company Inc.

Donaldson is a leading manufacturer of filtration systems and replacement parts (including air filtration systems, liquid filtration systems, and dust, fume, and mist collectors). The company serves a diverse range of end markets, including construction, mining, agriculture, truck, and industrial. Its business is organized into three segments: mobile solutions, industrial solutions, and life sciences. Donaldson generated approximately $3.6 billion in revenue and $544 million in operating income in its fiscal 2024.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: